The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Insect Cell Expression Systems Market Research Report 2024
Synopsis
The global Insect Cell Expression Systems market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Insect Cell Expression Systems is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Insect Cell Expression Systems is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Insect Cell Expression Systems include Merck KGaA (Germany), Thermo Fisher Scientific Inc (US), Becton, Dickinson & Company (US), Agilent Technologies, Inc (US), QIAGEN N.V. (Netherlands), Takara Bio Inc. (Japan), Lonza Group Ltd. (Switzerland), Bio-Rad Laboratories, Inc (US) and GenScript Biotech Corporation (China), etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Insect Cell Expression Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insect Cell Expression Systems.
Report Scope
The Insect Cell Expression Systems market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Insect Cell Expression Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Insect Cell Expression Systems manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck KGaA (Germany)
Thermo Fisher Scientific Inc (US)
Becton, Dickinson & Company (US)
Agilent Technologies, Inc (US)
QIAGEN N.V. (Netherlands)
Takara Bio Inc. (Japan)
Lonza Group Ltd. (Switzerland)
Bio-Rad Laboratories, Inc (US)
GenScript Biotech Corporation (China)
Lucigen Corporation (US)
Synthetic Genomics Inc (US)
Promega Corporation (US)
New England Biolabs, Inc (US)
Sengenics (Singapore.)
Segment by Type
Reagents
Expression Vectors
Competent Cells
Instruments
Segment by Application
Therapeutic
Industrial
Research
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Insect Cell Expression Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Insect Cell Expression Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Insect Cell Expression Systems market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Insect Cell Expression Systems is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Insect Cell Expression Systems is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Insect Cell Expression Systems include Merck KGaA (Germany), Thermo Fisher Scientific Inc (US), Becton, Dickinson & Company (US), Agilent Technologies, Inc (US), QIAGEN N.V. (Netherlands), Takara Bio Inc. (Japan), Lonza Group Ltd. (Switzerland), Bio-Rad Laboratories, Inc (US) and GenScript Biotech Corporation (China), etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Insect Cell Expression Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insect Cell Expression Systems.
Report Scope
The Insect Cell Expression Systems market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Insect Cell Expression Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Insect Cell Expression Systems manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck KGaA (Germany)
Thermo Fisher Scientific Inc (US)
Becton, Dickinson & Company (US)
Agilent Technologies, Inc (US)
QIAGEN N.V. (Netherlands)
Takara Bio Inc. (Japan)
Lonza Group Ltd. (Switzerland)
Bio-Rad Laboratories, Inc (US)
GenScript Biotech Corporation (China)
Lucigen Corporation (US)
Synthetic Genomics Inc (US)
Promega Corporation (US)
New England Biolabs, Inc (US)
Sengenics (Singapore.)
Segment by Type
Reagents
Expression Vectors
Competent Cells
Instruments
Segment by Application
Therapeutic
Industrial
Research
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Insect Cell Expression Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Insect Cell Expression Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Insect Cell Expression Systems Market Overview
1.1 Product Overview and Scope of Insect Cell Expression Systems
1.2 Insect Cell Expression Systems Segment by Type
1.2.1 Global Insect Cell Expression Systems Market Value Comparison by Type (2024-2030)
1.2.2 Reagents
1.2.3 Expression Vectors
1.2.4 Competent Cells
1.2.5 Instruments
1.3 Insect Cell Expression Systems Segment by Application
1.3.1 Global Insect Cell Expression Systems Market Value by Application: (2024-2030)
1.3.2 Therapeutic
1.3.3 Industrial
1.3.4 Research
1.4 Global Insect Cell Expression Systems Market Size Estimates and Forecasts
1.4.1 Global Insect Cell Expression Systems Revenue 2019-2030
1.4.2 Global Insect Cell Expression Systems Sales 2019-2030
1.4.3 Global Insect Cell Expression Systems Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Insect Cell Expression Systems Market Competition by Manufacturers
2.1 Global Insect Cell Expression Systems Sales Market Share by Manufacturers (2019-2024)
2.2 Global Insect Cell Expression Systems Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Insect Cell Expression Systems Average Price by Manufacturers (2019-2024)
2.4 Global Insect Cell Expression Systems Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Insect Cell Expression Systems, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Insect Cell Expression Systems, Product Type & Application
2.7 Insect Cell Expression Systems Market Competitive Situation and Trends
2.7.1 Insect Cell Expression Systems Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Insect Cell Expression Systems Players Market Share by Revenue
2.7.3 Global Insect Cell Expression Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Insect Cell Expression Systems Retrospective Market Scenario by Region
3.1 Global Insect Cell Expression Systems Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Insect Cell Expression Systems Global Insect Cell Expression Systems Sales by Region: 2019-2030
3.2.1 Global Insect Cell Expression Systems Sales by Region: 2019-2024
3.2.2 Global Insect Cell Expression Systems Sales by Region: 2025-2030
3.3 Global Insect Cell Expression Systems Global Insect Cell Expression Systems Revenue by Region: 2019-2030
3.3.1 Global Insect Cell Expression Systems Revenue by Region: 2019-2024
3.3.2 Global Insect Cell Expression Systems Revenue by Region: 2025-2030
3.4 North America Insect Cell Expression Systems Market Facts & Figures by Country
3.4.1 North America Insect Cell Expression Systems Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Insect Cell Expression Systems Sales by Country (2019-2030)
3.4.3 North America Insect Cell Expression Systems Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Insect Cell Expression Systems Market Facts & Figures by Country
3.5.1 Europe Insect Cell Expression Systems Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Insect Cell Expression Systems Sales by Country (2019-2030)
3.5.3 Europe Insect Cell Expression Systems Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Insect Cell Expression Systems Market Facts & Figures by Country
3.6.1 Asia Pacific Insect Cell Expression Systems Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Insect Cell Expression Systems Sales by Country (2019-2030)
3.6.3 Asia Pacific Insect Cell Expression Systems Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Insect Cell Expression Systems Market Facts & Figures by Country
3.7.1 Latin America Insect Cell Expression Systems Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Insect Cell Expression Systems Sales by Country (2019-2030)
3.7.3 Latin America Insect Cell Expression Systems Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Insect Cell Expression Systems Market Facts & Figures by Country
3.8.1 Middle East and Africa Insect Cell Expression Systems Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Insect Cell Expression Systems Sales by Country (2019-2030)
3.8.3 Middle East and Africa Insect Cell Expression Systems Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Insect Cell Expression Systems Sales by Type (2019-2030)
4.1.1 Global Insect Cell Expression Systems Sales by Type (2019-2024)
4.1.2 Global Insect Cell Expression Systems Sales by Type (2025-2030)
4.1.3 Global Insect Cell Expression Systems Sales Market Share by Type (2019-2030)
4.2 Global Insect Cell Expression Systems Revenue by Type (2019-2030)
4.2.1 Global Insect Cell Expression Systems Revenue by Type (2019-2024)
4.2.2 Global Insect Cell Expression Systems Revenue by Type (2025-2030)
4.2.3 Global Insect Cell Expression Systems Revenue Market Share by Type (2019-2030)
4.3 Global Insect Cell Expression Systems Price by Type (2019-2030)
5 Segment by Application
5.1 Global Insect Cell Expression Systems Sales by Application (2019-2030)
5.1.1 Global Insect Cell Expression Systems Sales by Application (2019-2024)
5.1.2 Global Insect Cell Expression Systems Sales by Application (2025-2030)
5.1.3 Global Insect Cell Expression Systems Sales Market Share by Application (2019-2030)
5.2 Global Insect Cell Expression Systems Revenue by Application (2019-2030)
5.2.1 Global Insect Cell Expression Systems Revenue by Application (2019-2024)
5.2.2 Global Insect Cell Expression Systems Revenue by Application (2025-2030)
5.2.3 Global Insect Cell Expression Systems Revenue Market Share by Application (2019-2030)
5.3 Global Insect Cell Expression Systems Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck KGaA (Germany)
6.1.1 Merck KGaA (Germany) Corporation Information
6.1.2 Merck KGaA (Germany) Description and Business Overview
6.1.3 Merck KGaA (Germany) Insect Cell Expression Systems Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck KGaA (Germany) Insect Cell Expression Systems Product Portfolio
6.1.5 Merck KGaA (Germany) Recent Developments/Updates
6.2 Thermo Fisher Scientific Inc (US)
6.2.1 Thermo Fisher Scientific Inc (US) Corporation Information
6.2.2 Thermo Fisher Scientific Inc (US) Description and Business Overview
6.2.3 Thermo Fisher Scientific Inc (US) Insect Cell Expression Systems Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Thermo Fisher Scientific Inc (US) Insect Cell Expression Systems Product Portfolio
6.2.5 Thermo Fisher Scientific Inc (US) Recent Developments/Updates
6.3 Becton, Dickinson & Company (US)
6.3.1 Becton, Dickinson & Company (US) Corporation Information
6.3.2 Becton, Dickinson & Company (US) Description and Business Overview
6.3.3 Becton, Dickinson & Company (US) Insect Cell Expression Systems Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Becton, Dickinson & Company (US) Insect Cell Expression Systems Product Portfolio
6.3.5 Becton, Dickinson & Company (US) Recent Developments/Updates
6.4 Agilent Technologies, Inc (US)
6.4.1 Agilent Technologies, Inc (US) Corporation Information
6.4.2 Agilent Technologies, Inc (US) Description and Business Overview
6.4.3 Agilent Technologies, Inc (US) Insect Cell Expression Systems Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Agilent Technologies, Inc (US) Insect Cell Expression Systems Product Portfolio
6.4.5 Agilent Technologies, Inc (US) Recent Developments/Updates
6.5 QIAGEN N.V. (Netherlands)
6.5.1 QIAGEN N.V. (Netherlands) Corporation Information
6.5.2 QIAGEN N.V. (Netherlands) Description and Business Overview
6.5.3 QIAGEN N.V. (Netherlands) Insect Cell Expression Systems Sales, Revenue and Gross Margin (2019-2024)
6.5.4 QIAGEN N.V. (Netherlands) Insect Cell Expression Systems Product Portfolio
6.5.5 QIAGEN N.V. (Netherlands) Recent Developments/Updates
6.6 Takara Bio Inc. (Japan)
6.6.1 Takara Bio Inc. (Japan) Corporation Information
6.6.2 Takara Bio Inc. (Japan) Description and Business Overview
6.6.3 Takara Bio Inc. (Japan) Insect Cell Expression Systems Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Takara Bio Inc. (Japan) Insect Cell Expression Systems Product Portfolio
6.6.5 Takara Bio Inc. (Japan) Recent Developments/Updates
6.7 Lonza Group Ltd. (Switzerland)
6.6.1 Lonza Group Ltd. (Switzerland) Corporation Information
6.6.2 Lonza Group Ltd. (Switzerland) Description and Business Overview
6.6.3 Lonza Group Ltd. (Switzerland) Insect Cell Expression Systems Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Lonza Group Ltd. (Switzerland) Insect Cell Expression Systems Product Portfolio
6.7.5 Lonza Group Ltd. (Switzerland) Recent Developments/Updates
6.8 Bio-Rad Laboratories, Inc (US)
6.8.1 Bio-Rad Laboratories, Inc (US) Corporation Information
6.8.2 Bio-Rad Laboratories, Inc (US) Description and Business Overview
6.8.3 Bio-Rad Laboratories, Inc (US) Insect Cell Expression Systems Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Bio-Rad Laboratories, Inc (US) Insect Cell Expression Systems Product Portfolio
6.8.5 Bio-Rad Laboratories, Inc (US) Recent Developments/Updates
6.9 GenScript Biotech Corporation (China)
6.9.1 GenScript Biotech Corporation (China) Corporation Information
6.9.2 GenScript Biotech Corporation (China) Description and Business Overview
6.9.3 GenScript Biotech Corporation (China) Insect Cell Expression Systems Sales, Revenue and Gross Margin (2019-2024)
6.9.4 GenScript Biotech Corporation (China) Insect Cell Expression Systems Product Portfolio
6.9.5 GenScript Biotech Corporation (China) Recent Developments/Updates
6.10 Lucigen Corporation (US)
6.10.1 Lucigen Corporation (US) Corporation Information
6.10.2 Lucigen Corporation (US) Description and Business Overview
6.10.3 Lucigen Corporation (US) Insect Cell Expression Systems Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Lucigen Corporation (US) Insect Cell Expression Systems Product Portfolio
6.10.5 Lucigen Corporation (US) Recent Developments/Updates
6.11 Synthetic Genomics Inc (US)
6.11.1 Synthetic Genomics Inc (US) Corporation Information
6.11.2 Synthetic Genomics Inc (US) Insect Cell Expression Systems Description and Business Overview
6.11.3 Synthetic Genomics Inc (US) Insect Cell Expression Systems Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Synthetic Genomics Inc (US) Insect Cell Expression Systems Product Portfolio
6.11.5 Synthetic Genomics Inc (US) Recent Developments/Updates
6.12 Promega Corporation (US)
6.12.1 Promega Corporation (US) Corporation Information
6.12.2 Promega Corporation (US) Insect Cell Expression Systems Description and Business Overview
6.12.3 Promega Corporation (US) Insect Cell Expression Systems Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Promega Corporation (US) Insect Cell Expression Systems Product Portfolio
6.12.5 Promega Corporation (US) Recent Developments/Updates
6.13 New England Biolabs, Inc (US)
6.13.1 New England Biolabs, Inc (US) Corporation Information
6.13.2 New England Biolabs, Inc (US) Insect Cell Expression Systems Description and Business Overview
6.13.3 New England Biolabs, Inc (US) Insect Cell Expression Systems Sales, Revenue and Gross Margin (2019-2024)
6.13.4 New England Biolabs, Inc (US) Insect Cell Expression Systems Product Portfolio
6.13.5 New England Biolabs, Inc (US) Recent Developments/Updates
6.14 Sengenics (Singapore.)
6.14.1 Sengenics (Singapore.) Corporation Information
6.14.2 Sengenics (Singapore.) Insect Cell Expression Systems Description and Business Overview
6.14.3 Sengenics (Singapore.) Insect Cell Expression Systems Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Sengenics (Singapore.) Insect Cell Expression Systems Product Portfolio
6.14.5 Sengenics (Singapore.) Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Insect Cell Expression Systems Industry Chain Analysis
7.2 Insect Cell Expression Systems Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Insect Cell Expression Systems Production Mode & Process
7.4 Insect Cell Expression Systems Sales and Marketing
7.4.1 Insect Cell Expression Systems Sales Channels
7.4.2 Insect Cell Expression Systems Distributors
7.5 Insect Cell Expression Systems Customers
8 Insect Cell Expression Systems Market Dynamics
8.1 Insect Cell Expression Systems Industry Trends
8.2 Insect Cell Expression Systems Market Drivers
8.3 Insect Cell Expression Systems Market Challenges
8.4 Insect Cell Expression Systems Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
